🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

RecruitingNAAges 50 Years - anyAllJointResearch
NCT06971757 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up. The HAKA trial consists of three different work packages (WPs). This trial (WP1) investigates the 1-year follow-up, WP2 examines the 1

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Painful and disabled hip or knee joint resulting from osteoarthritis * Scheduled for primary THA or TKA surgery * Age 50 years or older at the time of THA or TKA * Capable and willing to complete questionnaires * Proficient in Dutch or English * Willing to provide informed consent Exclusion Criteria: * Other indication for surgery than osteoarthritis * Scheduled for hip or knee revision arthroplasty, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA * Already participating in this study due to a previous hip or knee surgery
💊

What it tests

  • Routine Follow-Up (RFU)
  • Check-Up on Demand (COD)
📍

Where

9 sites
OLVG
Amsterdam, Netherlands
Amphia
Breda, Netherlands
Deventer Ziekenhuis
Deventer, Netherlands
Admiraal de Ruyter Ziekenhuis
Goes, Netherlands
Martini Ziekenhuis
Groningen, Netherlands
Tergooi MC
Hilversum, Netherlands
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands
ZorgSaam Zeeuws Vlaanderen
Terneuzen, Netherlands

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy